Schodack, NY, United States of America

Robert G Christiansen


Average Co-Inventor Count = 1.7

ph-index = 3

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 1977-1992

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Mind of Robert G. Christiansen

Introduction

Robert G. Christiansen, a notable inventor based in Schodack, NY, has made significant contributions to the field of pharmaceuticals through his innovative work. With a portfolio of five patents, Christiansen is recognized for his advancements in antiandrogenic agents, which play a crucial role in various therapeutic applications.

Latest Patents

Christiansen's latest patents showcase his expertise in developing novel sulfonylsteroids and their applications. One of his noteworthy inventions is the "Antiandrogenic sulfonylsteroidofurans - 5'-Alkylsulfonylsteroido[3,2-b]furans," specifically the compound 5'-methylsulfonyl-5.alpha.-pregn-2-en-20-yno[3,2-b]furan-17.beta.-ol. This compound has a structural formula that is crucial for its effectiveness as an antiandrogenic agent, alongside the processes for its preparation and applications.

Another significant patent is focused on "Antiandrogenic sulfonylsteroidopyrazoles," particularly resulting in the creation of 1'-Sulfonylsteroido[3,2-c]pyrazoles. An example of this is (5.alpha.,17.alpha.)-1'-(methylsulfonyl)-1'H-pregn-20-yno[3,2-c]pyrazol-17-ol, which also serves as a vital antiandrogenic agent, complete with detailed methodologies for its preparation, use, and related compositions.

Career Highlights

Currently, Robert G. Christiansen is affiliated with Sterling Drug Inc., where he continues to develop groundbreaking pharmaceuticals. His passion for innovation in drug development is evident in his extensive patented work, significantly addressing medical challenges faced in hormone-related health issues.

Collaborations

Throughout his career, Christiansen has collaborated with esteemed colleagues, including Malcolm R. Bell and John L. Herrmann, Jr. These partnerships have further enhanced his research, leading to the creation of impactful pharmaceutical solutions.

Conclusion

Robert G. Christiansen's commitment to innovation in the pharmaceutical domain is commendable. With five patents to his name, his work continues to pave the way for future advancements in antiandrogenic therapies, showcasing the profound impact of dedicated inventors in the ongoing quest for medical breakthroughs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…